Advancing rheumatology through public relations
Promoting Arthritis Research to Congress and Others
The ACR works to promote clinical and basic research in arthritis and musculoskeletal disease through a variety of channels, including advocacy, working directly with the National Institutes of Health (NIH), and through the work of the ACR Research and Education Foundation.
RheumPAC: Advance Rheumatology on Capital Hill
One way to succeed in our mission of advancing rheumatology is to increase the ACR’s presence on Capitol Hill through grassroots and direct lobbying. However, for the rheumatology subspecialty to be most effective we must use all tools available to us, including RheumPAC, the ACR’s nonpartisan political action committee. RheumPAC demonstrates to members of Congress that the rheumatology subspecialty is committed to political action, educating policy makers, and improving healthcare for our patients.
Advocate from Your Office the Week of March 14
The ACR is urging the 112th Congress to address many issues important to rheumatology including appropriate reimbursement for specialty care, the repeated battle to avert Medicare payment cuts, funding for the pediatric subspecialty loan repayment program, continued fair reimbursement for dual-energy X-ray absorptiometry scans, and the need for increased research funding.
A Huge Thank You to 251 People
RheumPAC supporters are helping to advance rheumatology
Shake-up in Washington. What’s in Store for Health Policy in the 112th?
Congress returns to Washington this month, and there will be many new faces on Capitol Hill. The recent midterm election will bring significant changes to the 112th Congress, leaving many to wonder what this new dynamic means for health policy.
2011 Legislative Outlook Important for Rheumatology
Next year is shaping up to be an important year for rheumatology on Capitol Hill. Issues that remain unresolved by the last Congress include concerns within the Affordable Care Act, the need for a stable Medicare system with fair physician reimbursement, funding for the pediatric subspecialty loan repayment program, and appropriate reimbursement for specialty care. Most congressional leaders, newly elected or re-elected, know very little about arthritis and other rheumatic diseases. That is why it is critical that rheumatology professionals reach out and educate them on the importance of specialty care and the impact these diseases have on one’s quality of life.
DEXA Champion Visits Local Rheumatologist
Sen. Blanche Lincoln (D-Ark.) visited the Arthritis Center of the Ozarks in Fayetteville, Ark., in August to speak with local rheumatologist Michael Saitta, MD, to discuss the importance of access to osteoporosis screenings.
Increase Rheumatology’s Voice in the AMA
Each June, the American Medical Association’s (AMA’s) House of Delegates Annual Meeting is held in Chicago, gathering representatives from various medical state and specialty societies to discuss and develop official policies of the AMA.
Congress Approves Six-Month “Doc Fix”—Now What?
Congress’ May 24 vote to rescind the 21% Medicare pay cut for six months illustrates how important it is for rheumatology professionals and patients to be involved in the legislative process. It was the thousands of calls, e-mails, and letters from medical professionals and patients that spurred Congress to take action. However, the battle is not yet over. Medicare physician payments face the same 21% cut beginning December 1.
- « Previous Page
- 1
- …
- 5
- 6
- 7
- 8
- 9
- …
- 12
- Next Page »